ADESSO SE (ADN1.DE) Stock Fundamental Analysis
FRA:ADN1 - Deutsche Boerse Ag - DE000A0Z23Q5 - Common Stock - Currency: EUR
Overall ADN1 gets a fundamental rating of 5 out of 10. We evaluated ADN1 against 74 industry peers in the IT Services industry. ADN1 has an average financial health and profitability rating. ADN1 is not priced too expensively while it is growing strongly. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
In the past year ADN1 was profitable.
ADN1 had a positive operating cash flow in the past year.
In the past 5 years ADN1 has always been profitable.
In the past 5 years ADN1 always reported a positive cash flow from operatings.
1.2 Ratios
ADN1 has a Return On Assets of 1.90%. This is in the lower half of the industry: ADN1 underperforms 62.16% of its industry peers.
Looking at the Return On Equity, with a value of 8.43%, ADN1 is in line with its industry, outperforming 41.89% of the companies in the same industry.
The Return On Invested Capital of ADN1 (4.96%) is worse than 62.16% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ADN1 is significantly below the industry average of 20.68%.
The 3 year average ROIC (3.16%) for ADN1 is below the current ROIC(4.96%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.9% | ||
| ROE | 8.43% | ||
| ROIC | 4.96% |
ROA(3y)1.93%
ROA(5y)3.99%
ROE(3y)6.49%
ROE(5y)13.12%
ROIC(3y)3.16%
ROIC(5y)4.51%
1.3 Margins
With a Profit Margin value of 0.79%, ADN1 is not doing good in the industry: 64.86% of the companies in the same industry are doing better.
ADN1's Profit Margin has declined in the last couple of years.
ADN1's Operating Margin of 2.81% is on the low side compared to the rest of the industry. ADN1 is outperformed by 66.22% of its industry peers.
In the last couple of years the Operating Margin of ADN1 has declined.
ADN1 has a better Gross Margin (86.11%) than 77.03% of its industry peers.
In the last couple of years the Gross Margin of ADN1 has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.81% | ||
| PM (TTM) | 0.79% | ||
| GM | 86.11% |
OM growth 3Y-30%
OM growth 5Y-15.03%
PM growth 3Y-55.28%
PM growth 5Y-30.54%
GM growth 3Y-0.02%
GM growth 5Y-0.7%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ADN1 is destroying value.
The number of shares outstanding for ADN1 has been reduced compared to 1 year ago.
ADN1 has more shares outstanding than it did 5 years ago.
ADN1 has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.53 indicates that ADN1 is not in any danger for bankruptcy at the moment.
The Altman-Z score of ADN1 (3.53) is better than 72.97% of its industry peers.
ADN1 has a debt to FCF ratio of 6.11. This is a slightly negative value and a sign of low solvency as ADN1 would need 6.11 years to pay back of all of its debts.
ADN1's Debt to FCF ratio of 6.11 is on the low side compared to the rest of the industry. ADN1 is outperformed by 62.16% of its industry peers.
A Debt/Equity ratio of 1.53 is on the high side and indicates that ADN1 has dependencies on debt financing.
The Debt to Equity ratio of ADN1 (1.53) is worse than 77.03% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.53 | ||
| Debt/FCF | 6.11 | ||
| Altman-Z | 3.53 |
ROIC/WACC0.91
WACC5.46%
2.3 Liquidity
A Current Ratio of 1.20 indicates that ADN1 should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.20, ADN1 is in line with its industry, outperforming 47.30% of the companies in the same industry.
ADN1 has a Quick Ratio of 1.20. This is a normal value and indicates that ADN1 is financially healthy and should not expect problems in meeting its short term obligations.
ADN1's Quick ratio of 1.20 is in line compared to the rest of the industry. ADN1 outperforms 55.41% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.2 | ||
| Quick Ratio | 1.2 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 188.20% over the past year.
Measured over the past years, ADN1 shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -15.07% on average per year.
The Revenue has grown by 13.80% in the past year. This is quite good.
The Revenue has been growing by 23.60% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)188.2%
EPS 3Y-45.19%
EPS 5Y-15.07%
EPS Q2Q%-8.73%
Revenue 1Y (TTM)13.8%
Revenue growth 3Y24.12%
Revenue growth 5Y23.6%
Sales Q2Q%11.44%
3.2 Future
Based on estimates for the next years, ADN1 will show a very strong growth in Earnings Per Share. The EPS will grow by 38.92% on average per year.
ADN1 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.44% yearly.
EPS Next Y121.81%
EPS Next 2Y77.37%
EPS Next 3Y65.85%
EPS Next 5Y38.92%
Revenue Next Year9.93%
Revenue Next 2Y10.1%
Revenue Next 3Y9.9%
Revenue Next 5Y9.44%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 36.11, ADN1 can be considered very expensive at the moment.
Based on the Price/Earnings ratio, ADN1 is valued a bit more expensive than 63.51% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.30, ADN1 is valued a bit more expensive.
ADN1 is valuated correctly with a Price/Forward Earnings ratio of 15.04.
Based on the Price/Forward Earnings ratio, ADN1 is valued a bit cheaper than the industry average as 63.51% of the companies are valued more expensively.
ADN1 is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.11 | ||
| Fwd PE | 15.04 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ADN1 is valued a bit cheaper than 66.22% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ADN1 is valued a bit cheaper than 71.62% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.68 | ||
| EV/EBITDA | 6.9 |
4.3 Compensation for Growth
ADN1's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ADN1's earnings are expected to grow with 65.85% in the coming years.
PEG (NY)0.3
PEG (5Y)N/A
EPS Next 2Y77.37%
EPS Next 3Y65.85%
5. Dividend
5.1 Amount
ADN1 has a yearly dividend return of 0.83%, which is pretty low.
ADN1's Dividend Yield is comparable with the industry average which is at 6.89.
Compared to an average S&P500 Dividend Yield of 2.37, ADN1's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.83% |
5.2 History
The dividend of ADN1 is nicely growing with an annual growth rate of 15.65%!
Dividend Growth(5Y)15.65%
Div Incr Years5
Div Non Decr Years6
5.3 Sustainability
ADN1 pays out 41.03% of its income as dividend. This is a bit on the high side, but may be sustainable.
ADN1's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP41.03%
EPS Next 2Y77.37%
EPS Next 3Y65.85%
FRA:ADN1 (7/11/2025, 7:00:00 PM)
86.3
-0.2 (-0.23%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners16.98%
Inst Owner ChangeN/A
Ins Owners49.36%
Ins Owner ChangeN/A
Market Cap562.68M
Analysts78.46
Price Target126.63 (46.73%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.83% |
Yearly Dividend0.94
Dividend Growth(5Y)15.65%
DP41.03%
Div Incr Years5
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.81%
PT rev (3m)0.58%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-8.49%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.22%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 36.11 | ||
| Fwd PE | 15.04 | ||
| P/S | 0.28 | ||
| P/FCF | 9.68 | ||
| P/OCF | 6.35 | ||
| P/B | 3.05 | ||
| P/tB | 12.41 | ||
| EV/EBITDA | 6.9 |
EPS(TTM)2.39
EY2.77%
EPS(NY)5.74
Fwd EY6.65%
FCF(TTM)8.91
FCFY10.33%
OCF(TTM)13.58
OCFY15.74%
SpS303.77
BVpS28.27
TBVpS6.95
PEG (NY)0.3
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.9% | ||
| ROE | 8.43% | ||
| ROCE | 11.28% | ||
| ROIC | 4.96% | ||
| ROICexc | 5.55% | ||
| ROICexgc | 8.11% | ||
| OM | 2.81% | ||
| PM (TTM) | 0.79% | ||
| GM | 86.11% | ||
| FCFM | 2.93% |
ROA(3y)1.93%
ROA(5y)3.99%
ROE(3y)6.49%
ROE(5y)13.12%
ROIC(3y)3.16%
ROIC(5y)4.51%
ROICexc(3y)4.06%
ROICexc(5y)6.01%
ROICexgc(3y)6.65%
ROICexgc(5y)10.11%
ROCE(3y)7.2%
ROCE(5y)10.26%
ROICexcg growth 3Y-20.34%
ROICexcg growth 5Y-12.01%
ROICexc growth 3Y-21.84%
ROICexc growth 5Y-11.01%
OM growth 3Y-30%
OM growth 5Y-15.03%
PM growth 3Y-55.28%
PM growth 5Y-30.54%
GM growth 3Y-0.02%
GM growth 5Y-0.7%
F-Score5
Asset Turnover2.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.53 | ||
| Debt/FCF | 6.11 | ||
| Debt/EBITDA | 2.25 | ||
| Cap/Depr | 43.76% | ||
| Cap/Sales | 1.54% | ||
| Interest Coverage | 4.12 | ||
| Cash Conversion | 70.77% | ||
| Profit Quality | 373.76% | ||
| Current Ratio | 1.2 | ||
| Quick Ratio | 1.2 | ||
| Altman-Z | 3.53 |
F-Score5
WACC5.46%
ROIC/WACC0.91
Cap/Depr(3y)52.06%
Cap/Depr(5y)49.68%
Cap/Sales(3y)2.64%
Cap/Sales(5y)2.54%
Profit Quality(3y)790.41%
Profit Quality(5y)538.39%
High Growth Momentum
Growth
EPS 1Y (TTM)188.2%
EPS 3Y-45.19%
EPS 5Y-15.07%
EPS Q2Q%-8.73%
EPS Next Y121.81%
EPS Next 2Y77.37%
EPS Next 3Y65.85%
EPS Next 5Y38.92%
Revenue 1Y (TTM)13.8%
Revenue growth 3Y24.12%
Revenue growth 5Y23.6%
Sales Q2Q%11.44%
Revenue Next Year9.93%
Revenue Next 2Y10.1%
Revenue Next 3Y9.9%
Revenue Next 5Y9.44%
EBIT growth 1Y40.74%
EBIT growth 3Y-13.12%
EBIT growth 5Y5.01%
EBIT Next Year308.55%
EBIT Next 3Y80.4%
EBIT Next 5Y42.55%
FCF growth 1Y788.49%
FCF growth 3Y40.19%
FCF growth 5Y49.54%
OCF growth 1Y154.02%
OCF growth 3Y32.14%
OCF growth 5Y37.69%